Skip to main content
. 2022 Dec 3;11(12):2402. doi: 10.3390/antiox11122402

Table 5.

Synaptic therapeutics of interest.

Drug Name Therapy Type Condition Status
AZD0530 Small molecule therapy Alzheimer’s Disease, Parkinson’s Disease AD (Discontinued), PD (Phase 1)
CT1812 (Elayta) Small molecule therapy Alzheimer’s disease (Phase 2)